Losper, K. C., & Swanepoel, C. (2025). Design and validation of molecular diagnostic assays for key prognostic biomarkers, FLT3-ITD, NPM1, DNMT3A and CEBPA in cytogenetically normal aml patients at Tygerberg Hospital, South Africa. Stellenbosch : Stellenbosch University.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
Losper, Kaylee Chantel, and Carmen Swanepoel. Design and Validation of Molecular Diagnostic Assays for Key Prognostic Biomarkers, FLT3-ITD, NPM1, DNMT3A and CEBPA in Cytogenetically Normal Aml Patients at Tygerberg Hospital, South Africa. Stellenbosch : Stellenbosch University, 2025.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
Losper, Kaylee Chantel, and Carmen Swanepoel. Design and Validation of Molecular Diagnostic Assays for Key Prognostic Biomarkers, FLT3-ITD, NPM1, DNMT3A and CEBPA in Cytogenetically Normal Aml Patients at Tygerberg Hospital, South Africa. Stellenbosch : Stellenbosch University, 2025.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.